Literature DB >> 6681770

Low- and high-risk malignant melanoma--III. Prognostic significance of the resection margin.

C Schmoeckel, A Bockelbrink, H Bockelbrink, H Kistler, O Braun-Falco.   

Abstract

The influence of the resection margin on the prognosis of malignant melanoma was investigated in 577 cases (stage I), 285 with later recurrences and 292 disease-free for at least 5 yr. The resection margins varied considerably, with less than or equal to 10 mm in 172 cases and ca. 50 mm in 85 cases. Low- and high-risk melanomas (determined by means of tumor thickness and mitotic index) were found to be distributed evenly, with only minor variations for different resection margins. The occurrence of metastases was found to be independent of the resection margin, and several statistical methods were used (correlation coefficients, chi-square tests, discriminant analyses). This was also true when high-risk cases were analyzed separately. In contrast, for low-risk melanoma (68 cases), the six metastatic cases had a resection margin less than or equal to 20 mm (11.8% vs 0%, P = 0.3). Furthermore, local recurrences (40 in 482 cases) were seen more frequently in cases with a resection margin less than 30 mm (10.0 vs 2.9%, P = 0.02). However, local recurrences did not appear to be responsible for disseminated disease, as 82.1% were at high and 10.3% were at medium risk. The benefit of a 5-cm resection margin could not be substantiated in this study. A 3-cm resection margin may be necessary to lower the risk of local recurrences and a 2-cm margin appeared to be sufficient for low-risk melanoma.

Entities:  

Mesh:

Year:  1983        PMID: 6681770     DOI: 10.1016/0277-5379(83)90423-6

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  8 in total

1.  Professor Dr. Dr. h. c. Otto Braun-Falco.

Authors: 
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

2.  At least one centimetre for each millimetre.

Authors:  F H Rampen
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-29

Review 3.  Surgical management of primary melanoma.

Authors:  D Costello; A Powers; J Lynn; C W Cruse; D Reintgen
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

Review 4.  Cure and cosmesis in the management of primary malignant melanoma.

Authors:  G T Neades; L E Hughes
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

5.  The role of fibronectin in tumor implantation at surgical sites.

Authors:  M S Murthy; E F Scanlon; R H Silverman; C R Goodheart; R A Goldschmidt; M L Jelachich
Journal:  Clin Exp Metastasis       Date:  1993-03       Impact factor: 5.150

6.  Nevoid malignant melanoma.

Authors:  C Schmoeckel; C E Castro; O Braun-Falco
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

7.  Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (less than or equal to 1.5 mm) melanoma.

Authors:  C Kuehnl-Petzoldt; H Keil; E Schoepf
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

8.  Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical stage I. A multivariate regression analysis.

Authors:  K Søndergaard; G Schou
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.